Skip to main content

Serigne N. Lo, PhDGabrielle J. Williams, PhDAnne E. Cust, PhDDavid W. Ollila, MDAlexander H. R. Varey, MBChB, PhDSydney Ch’ng, MD, PhDRichard A. Scolyer, MDJohn F. Thompson, MD

Abstract

Importance: Most patients who present with primary cutaneous melanomas have thin tumors (≤1.0 mm in Breslow thickness, ie, pT1a and pT1b). Although their prognosis is generally considered to be excellent, there is limited precise information on the association of risk of death with specific Breslow measurements in thin lesions.

Objective: To assess the relative effect of a 0.8-mm Breslow thickness threshold with respect to the incidence of both melanoma-related and nonmelanoma-related death.

Design, setting, and participants: Registry data for all Australians diagnosed with thin invasive primary melanomas between 1982 and 2014 were analyzed. Data were extracted from all 8 Australian state and territory population-based cancer registries. Dates and causes of death were obtained from the Australian National Death Index. Adults diagnosed with a first invasive primary melanoma of 1.0 mm or smaller in thickness were included.

Exposure: First invasive primary melanoma between 1982 and 2014.

To read more of this article please click here.

MoleMax Systems
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.